BBLG Q3 2020 Earnings — Bone Biologics Corporation Revenue & Financial Results | Market Cap Arena

BBLGBone Biologics Corporation

$2M

Q3 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$145,823

Net Income

-$394,049

EPS (Diluted)

$-7.71

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$72,228

Free Cash Flow

-$72,230

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$2,461

Total Liabilities

$13M

Stockholders' Equity

-$13M

Cash & Equivalents

$2,461

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$145,823	-$301,000	+51.6%
Net Income	-$394,049	-$561,000	+29.8%